- Report
- February 2024
- 50 Pages
Global
From €2166EUR$2,400USD£1,878GBP
- Report
- December 2023
- 220 Pages
Global
From €2978EUR$3,300USD£2,582GBP
- Report
- June 2022
- 1500 Pages
Global
From €3520EUR$3,900USD£3,052GBP
- Report
- February 2022
- 360 Pages
United States
From €3249EUR$3,600USD£2,817GBP
- Report
- November 2021
- 222 Pages
Global
From €2708EUR$3,000USD£2,347GBP
- Report
- October 2021
- 78 Pages
Global
From €722EUR$800USD£626GBP
- Report
- April 2025
- 388 Pages
Global
From €4197EUR$4,650USD£3,638GBP
- Report
- November 2024
- 136 Pages
Global
From €4197EUR$4,650USD£3,638GBP
- Report
- August 2024
- 112 Pages
Global
From €4197EUR$4,650USD£3,638GBP
- Report
- May 2023
United States
From €1354EUR$1,500USD£1,174GBP
- Report
- March 2023
Germany
From €1354EUR$1,500USD£1,174GBP
- Report
- November 2022
- 197 Pages
United States
From €3385EUR$3,750USD£2,934GBP
- Report
- January 2022
- 292 Pages
Global
From €3385EUR$3,750USD£2,934GBP
- Report
- April 2025
- 203 Pages
Global
From €4197EUR$4,650USD£3,638GBP
- Report
- March 2025
- 160 Pages
Global
From €4197EUR$4,650USD£3,638GBP
- Report
- March 2025
- 211 Pages
Global
From €4197EUR$4,650USD£3,638GBP
- Report
- October 2024
- 181 Pages
Global
From €4197EUR$4,650USD£3,638GBP
- Report
- December 2021
- 353 Pages
Global
From €4964EUR$5,500USD£4,304GBP
- Report
- September 2023
- 98 Pages
Global
From €5370EUR$5,950USD£4,656GBP
- Report
- July 2024
- 100 Pages
Global
From €5370EUR$5,950USD£4,656GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more